STOCK TITAN

[144] The Joint Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The filer submitted a Form 144 to notify a proposed sale of 20,000 common shares of The Joint Corp. (JYNT) through Raymond James & Associates on NASDAQ, with an aggregate market value of $215,000 and approximately 15,340,000 shares outstanding. The shares were acquired by the same person through two stock option exercises: 10,289 shares on 08/22/2025 and 9,711 shares on 08/25/2025, each paid in cash on the exercise dates. The filer reports no securities sold in the past three months. The form includes the routine certification that the seller is not aware of undisclosed material adverse information. Certain filer identification fields in the provided content are blank.

Il dichiarante ha presentato un Modulo 144 per notificare la prevista vendita di 20.000 azioni ordinarie di The Joint Corp. (JYNT) tramite Raymond James & Associates sul NASDAQ, per un valore di mercato complessivo di 215.000 USD e con circa 15.340.000 azioni in circolazione. Le azioni erano state acquisite dalla medesima persona mediante l’esercizio di due opzioni su azioni: 10.289 azioni il 22/08/2025 e 9.711 azioni il 25/08/2025, entrambe pagate in contanti alle rispettive date di esercizio. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi. Il modulo contiene la consueta dichiarazione che il venditore non è a conoscenza di informazioni materiali negative non divulgate. Alcuni campi identificativi del dichiarante nel contenuto fornito risultano vuoti.

El declarante presentó un Formulario 144 para notificar la propuesta venta de 20.000 acciones ordinarias de The Joint Corp. (JYNT) a través de Raymond James & Associates en NASDAQ, con un valor de mercado agregado de 215.000 USD y aproximadamente 15.340.000 acciones en circulación. Las acciones fueron adquiridas por la misma persona mediante el ejercicio de dos opciones sobre acciones: 10.289 acciones el 22/08/2025 y 9.711 acciones el 25/08/2025, ambas pagadas en efectivo en las fechas de ejercicio. El declarante informa no haber vendido valores en los últimos tres meses. El formulario incluye la certificación rutinaria de que el vendedor no tiene conocimiento de información material adversa no divulgada. Algunos campos de identificación del declarante en el contenido proporcionado están en blanco.

신고인은 NASDAQ에서 Raymond James & Associates를 통해 The Joint Corp.(JYNT) 보통주 20,000주를 매도할 예정임을 통지하기 위해 Form 144를 제출했으며, 총 시가 가치는 215,000달러이고 발행 주식수는 약 15,340,000주입니다. 해당 주식은 동일인이 두 차례 스톡옵션을 행사하여 취득한 것으로, 2025-08-22에 10,289주, 2025-08-25에 9,711주를 각각 행사일에 현금으로 지급해 취득했습니다. 신고인은 지난 3개월간 매도한 증권이 없음을 보고했습니다. 양식에는 매도자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 통상적인 확인서가 포함되어 있습니다. 제공된 내용에서 일부 신고인 식별 항목은 비어 있습니다.

Le déclarant a déposé un formulaire 144 pour notifier la vente projetée de 20 000 actions ordinaires de The Joint Corp. (JYNT) via Raymond James & Associates sur le NASDAQ, pour une valeur marchande totale de 215 000 USD et environ 15 340 000 actions en circulation. Les actions ont été acquises par la même personne lors de l’exercice de deux options sur actions : 10 289 actions le 22/08/2025 et 9 711 actions le 25/08/2025, payées en espèces aux dates d’exercice respectives. Le déclarant déclare n’avoir vendu aucun titre au cours des trois derniers mois. Le formulaire comporte la certification habituelle selon laquelle le vendeur n’a pas connaissance d’informations défavorables importantes non divulguées. Certains champs d’identification du déclarant dans le contenu fourni sont laissés vides.

Der Melder reichte ein Formular 144 ein, um einen geplanten Verkauf von 20.000 Stammaktien der The Joint Corp. (JYNT) über Raymond James & Associates an der NASDAQ zu melden. Der Gesamtkapitalwert beträgt 215.000 USD, bei rund 15.340.000 ausstehenden Aktien. Die Aktien wurden von derselben Person durch Ausübung von zwei Aktienoptionen erworben: 10.289 Aktien am 22.08.2025 und 9.711 Aktien am 25.08.2025; beide Ausübungen wurden an den jeweiligen Daten bar bezahlt. Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben. Das Formular enthält die routinemäßige Bestätigung, dass dem Verkäufer keine nicht offen gelegten wesentlichen nachteiligen Informationen bekannt sind. Bestimmte Identifikationsfelder des Melders im vorliegenden Inhalt sind leer.

Positive
  • Planned sale disclosed with broker, exchange, date, and aggregate value provided
  • Acquisitions were paid in cash on exercise dates, indicating straightforward consideration
  • No sales in past three months reported, suggesting this is not part of a recent pattern of dispositions
Negative
  • Filer identification fields appear blank in the provided extract, reducing traceability of the seller
  • Limited contextual detail in this excerpt (no filer CIK, contact name or issuer address shown)

Insights

TL;DR: Insider plans to sell 20,000 shares acquired by option exercise; routine disclosure with limited market impact.

The filing discloses a proposed sale equal to 0.13% of the reported outstanding shares (20,000 of 15,340,000). The shares were recently acquired by exercise and paid for in cash, indicating no complex consideration arrangements. There are no reported sales in the prior three months, so this notice appears to reflect an initial monetization of newly exercised options rather than continued disposition. The filing lacks explicit filer identifiers in the provided extract, which reduces traceability.

TL;DR: Documentation is standard Rule 144 notice; disclosure meets basic requirements but omits some filer contact fields in this excerpt.

The submission follows Rule 144 format: broker, planned sale date, class, acquisition dates, and payment method are stated. The representation about lack of material nonpublic information is included as required. From a governance perspective, the transaction appears routine and transparent in form; the missing filer CIK/contact details in the provided content should be confirmed in the full filing record for completeness.

Il dichiarante ha presentato un Modulo 144 per notificare la prevista vendita di 20.000 azioni ordinarie di The Joint Corp. (JYNT) tramite Raymond James & Associates sul NASDAQ, per un valore di mercato complessivo di 215.000 USD e con circa 15.340.000 azioni in circolazione. Le azioni erano state acquisite dalla medesima persona mediante l’esercizio di due opzioni su azioni: 10.289 azioni il 22/08/2025 e 9.711 azioni il 25/08/2025, entrambe pagate in contanti alle rispettive date di esercizio. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi. Il modulo contiene la consueta dichiarazione che il venditore non è a conoscenza di informazioni materiali negative non divulgate. Alcuni campi identificativi del dichiarante nel contenuto fornito risultano vuoti.

El declarante presentó un Formulario 144 para notificar la propuesta venta de 20.000 acciones ordinarias de The Joint Corp. (JYNT) a través de Raymond James & Associates en NASDAQ, con un valor de mercado agregado de 215.000 USD y aproximadamente 15.340.000 acciones en circulación. Las acciones fueron adquiridas por la misma persona mediante el ejercicio de dos opciones sobre acciones: 10.289 acciones el 22/08/2025 y 9.711 acciones el 25/08/2025, ambas pagadas en efectivo en las fechas de ejercicio. El declarante informa no haber vendido valores en los últimos tres meses. El formulario incluye la certificación rutinaria de que el vendedor no tiene conocimiento de información material adversa no divulgada. Algunos campos de identificación del declarante en el contenido proporcionado están en blanco.

신고인은 NASDAQ에서 Raymond James & Associates를 통해 The Joint Corp.(JYNT) 보통주 20,000주를 매도할 예정임을 통지하기 위해 Form 144를 제출했으며, 총 시가 가치는 215,000달러이고 발행 주식수는 약 15,340,000주입니다. 해당 주식은 동일인이 두 차례 스톡옵션을 행사하여 취득한 것으로, 2025-08-22에 10,289주, 2025-08-25에 9,711주를 각각 행사일에 현금으로 지급해 취득했습니다. 신고인은 지난 3개월간 매도한 증권이 없음을 보고했습니다. 양식에는 매도자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 통상적인 확인서가 포함되어 있습니다. 제공된 내용에서 일부 신고인 식별 항목은 비어 있습니다.

Le déclarant a déposé un formulaire 144 pour notifier la vente projetée de 20 000 actions ordinaires de The Joint Corp. (JYNT) via Raymond James & Associates sur le NASDAQ, pour une valeur marchande totale de 215 000 USD et environ 15 340 000 actions en circulation. Les actions ont été acquises par la même personne lors de l’exercice de deux options sur actions : 10 289 actions le 22/08/2025 et 9 711 actions le 25/08/2025, payées en espèces aux dates d’exercice respectives. Le déclarant déclare n’avoir vendu aucun titre au cours des trois derniers mois. Le formulaire comporte la certification habituelle selon laquelle le vendeur n’a pas connaissance d’informations défavorables importantes non divulguées. Certains champs d’identification du déclarant dans le contenu fourni sont laissés vides.

Der Melder reichte ein Formular 144 ein, um einen geplanten Verkauf von 20.000 Stammaktien der The Joint Corp. (JYNT) über Raymond James & Associates an der NASDAQ zu melden. Der Gesamtkapitalwert beträgt 215.000 USD, bei rund 15.340.000 ausstehenden Aktien. Die Aktien wurden von derselben Person durch Ausübung von zwei Aktienoptionen erworben: 10.289 Aktien am 22.08.2025 und 9.711 Aktien am 25.08.2025; beide Ausübungen wurden an den jeweiligen Daten bar bezahlt. Der Melder gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben. Das Formular enthält die routinemäßige Bestätigung, dass dem Verkäufer keine nicht offen gelegten wesentlichen nachteiligen Informationen bekannt sind. Bestimmte Identifikationsfelder des Melders im vorliegenden Inhalt sind leer.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for JYNT disclose about the proposed sale?

The form discloses a proposed sale of 20,000 common shares via Raymond James with an aggregate value of $215,000 and an expected sale date of 08/22/2025.

How and when were the shares being sold acquired according to the filing?

The shares were acquired by stock option exercises: 10,289 shares on 08/22/2025 and 9,711 shares on 08/25/2025, with payment in cash on those dates.

Does the filing show prior sales by the same person in the last three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Through which broker and exchange is the sale scheduled?

The sale is scheduled through Raymond James & Associates and the securities are listed on NASDAQ.

What outstanding share count and percentage does this proposed sale represent?

The filing lists 15,340,000 shares outstanding; the proposed sale of 20,000 shares equals approximately 0.13% of that amount.
Joint Corp

NASDAQ:JYNT

JYNT Rankings

JYNT Latest News

JYNT Latest SEC Filings

JYNT Stock Data

162.79M
13.74M
10.38%
77.57%
3.58%
Medical Care Facilities
Patent Owners & Lessors
Link
United States
SCOTTSDALE